Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 4:36 pm Purchase | 2025-09-25 | 13D | Bio-Rad Laboratories, Inc. BIO | Norman D. Schwartz | 4,929,036 97.200% | 1,700,114 (+52.65%) | Filing History |
| 2025-10-30 4:35 pm Sale | 2025-09-25 | 13D | Bio-Rad Laboratories, Inc. BIO | Norman D. Schwartz | 3,228,922 14.600% | -1,700,114 (-34.49%) | Filing History |
| 2025-10-28 4:30 pm Purchase | 2025-09-25 | 13D | Bio-Rad Laboratories, Inc. BIO | Norman D. Schwartz | 4,929,036 97.200% | 1,700,114 (+52.65%) | Filing History |
| 2025-10-28 4:30 pm Purchase | 2025-09-25 | 13D | Bio-Rad Laboratories, Inc. BIO | Norman D. Schwartz | 3,228,922 14.600% | 3,228,922 (New Position) | Filing History |
| 2025-10-17 6:40 pm Sale | 2025-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,618,123 7.400% | -311,741 (-16.15%) | Filing History |
| 2025-08-06 1:35 pm Purchase | 2025-06-30 | 13G | Bio-Rad Laboratories, Inc. BIO | First Eagle Investment Management, LLC | 2,528,321 11.400% | 234,060 (+10.20%) | Filing History |
| 2025-07-18 2:17 pm Sale | 2025-05-01 | 13D | Bio-Rad Laboratories, Inc. BIO | Alice N. Schwartz | 2,732,073 12.300% | -5,600 (-0.20%) | Filing History |
| 2025-05-05 12:52 pm Purchase | 2025-04-30 | 13G | Bio-Rad Laboratories, Inc. BIO | First Eagle Investment Management, LLC | 2,294,261 10.000% | 724,479 (+46.15%) | Filing History |
| 2025-05-05 12:16 pm Purchase | 2025-03-31 | 13G | Bio-Rad Laboratories, Inc. BIO | First Eagle Investment Management, LLC | 1,569,782 6.800% | 1,569,782 (New Position) | Filing History |
| 2025-03-04 7:06 pm Purchase | 2025-02-10 | 13G | OncoCyte Corporation OCX | BIO-RAD LABORATORIES INC. BIO | 2,764,078 9.700% | 2,764,078 (New Position) | Filing History |
| 2024-12-20 4:50 pm Purchase | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 1,907,640 8.370% | 1,716,876 (+900.00%) | Filing History |
| 2024-11-14 5:25 pm Purchase | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | VAN ECK ASSOCIATES CORP | 1,306,473 5.730% | 1,306,473 (New Position) | Filing History |
| 2024-11-12 1:27 pm Unchanged | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 190,764 8.360% | 0 (Unchanged) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,929,864 8.500% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:22 am Sale | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 190,764 8.360% | -2,236,373 (-92.14%) | Filing History |
| 2024-10-24 12:13 pm Purchase | 2024-10-04 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | BIO-RAD LABORATORIES INC. BIO | 1,510,944 8.970% | 1,510,944 (New Position) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,929,864 8.500% | 463,638 (+31.62%) | Filing History |
| 2024-10-10 11:38 am Sale | 2023-12-29 | 13G | Bio-Rad Laboratories, Inc. BIO | BANK OF NOVA SCOTIA | 22,572 0.090% | -1,581,474 (-98.59%) | Filing |
| 2024-10-10 11:36 am Purchase | 2022-12-30 | 13G | Bio-Rad Laboratories, Inc. BIO | BANK OF NOVA SCOTIA | 1,604,046 6.500% | 1,604,046 (New Position) | Filing |
| 2024-04-22 1:30 pm Purchase | 2024-04-15 | 13G | Bio-Rad Laboratories, Inc. BIO | BIO-RAD LABORATORIES INC. BIO | 1,200,109 8.990% | 1,200,109 (New Position) | Filing History |